Introduction:

Amniotic Membrane Market was valued at US$ 4.0 billion in 2024 and is projected to grow at a CAGR of 13.60% to reach US$ 12.8 billion by 2034.

The amniotic membrane is the innermost layer of the placenta that helps to development of the fetus during the pregnancy is known as an amniotic membrane. It comprises a single epithelium layer, an avascular stromal matrix, and a thick basement membrane. Moreover, it has an anti-scarring effect and an anti-inflammatory effect. This membrane functions as a basement membrane substitute in the eye and acts as a temporary graft. Thus, it can be used in the treatment if various defects of the corneal epithelia. This is based on the lyophilized human amniotic membrane which allows the topical application to the ocular surface of endless quantities of amniotic membrane biological factors.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

COVID-19 Impact on the Market:

With the outbreak of the COVID-19, various businesses are at the forefront to combat this pandemic. The pandemic has hindered the industrial supply chain and also disrupted the production segment. Government across the countries has imposed strict lockdown to limit the spread of disease. However, increasing investments by prominent players and other industries has created growth opportunities, during this chaotic situation, to fulfill the demand of suppliers. This report will quantify the impact of this pandemic on the amniotic membrane market.

Rising awareness regarding benefits of amniotic membrane

Rising awareness in the recent past has led to a surge in the number of transplants leading to increasing demand for these tissue-based products. It has also led to a rise in the number of donations thus, fueling market growth.

High demands for cosmetic surgeries which drives the market

Increased use of the amniotic membrane in ophthalmic plastic and reconstructive surgeries to ease scarring and diagnose quickly is driving the global market growth. In addition, the growing number of patients opting for surgeries, for the aesthetic appeal, is also propelling the growth of the amniotic membrane market. For instance, in 2018, according to the American Society of Plastic Surgeons, 17.7 million cosmetic procedures were performed. Amniotic membranes are cheaper as compared to the xenografts and allografts, which in turn promotes market growth. Also, growth in product demand for cosmetic surgeries and reconstructive surgeries is fueling the overall market growth.

However, the lack of standardized guidelines on tissue and biomedical engineering and a dearth of skilled/experienced professionals to perform AMT are factors limiting the growth of the market.

The amniotic membrane market is segmented based on the type, application, end-user, and region.

Depending upon the type, the global business is categorized into cryopreserved amniotic membrane and lyophilized amniotic membrane. In terms of application, the worldwide industry is categorized into surgical wounds, ophthalmology, stem cell biology, regenerative medicine, prenatal diagnosis, and others. Based on the end-user, the target market is segmented into hospitals & clinics, ambulatory surgical centers, research centers & laboratory, and others.

Regional Insights:

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Regionally, the overall industry is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the target market in 2019, owing to the presence of the leading companies and well-developed healthcare infrastructure. In addition, increased focus on alternative technologies and the adoption of advanced technologies is further expected to boost the growth of the market in this region. Europe estimated for the second-largest revenue and is projected to register a CAGR of 11.9% in the upcoming years. The adoption of publicly funded universal health care systems and the presence of the target population are the key major factors for the growth of the global market. Furthermore, the growing prevalence of chronic diseases is anticipated to accelerate market growth in this region. According to the World Health Organization (WHO), chronic diseases account for about 86% of deaths in the European region. Asia Pacific is anticipated to grow at the highest CAGR over the forecast period. A gradual increase in disposable income and economic developments in the region are boosting the growth of the market. Additionally, technological advancements from the leading players in the market are likely to help boost the market growth in APAC.

Report Scope:

Attribute	Details
Market Size 2024	US$ 4.0 billion
Projected Market Size 2034	US$ 12.8 billion
CAGR Growth Rate	13.60%
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Type - Cryopreserved Amniotic Membrane and Lyophilized Amniotic Membrane By Application - Surgical Wounds, Ophthalmology, Stem Cell Biology, Regenerative Medicine, Prenatal Diagnosis, and Others By End-user - Hospitals & Clinics, Ambulatory Surgical Centers, Research Centers & Laboratory, and Others.
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Amniotic Membrane Market report based on Type, Application, End-user and region:

Amniotic Membrane Market, By Type:

• Cryopreserved Amniotic Membrane
• Lyophilized Amniotic Membrane

 Amniotic Membrane Market, By Application:

• Surgical Wounds
• Ophthalmology
• Stem Cell Biology
• Regenerative Medicine
• Prenatal Diagnosis
• Others

Amniotic Membrane Market, By End-user:

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Research Centers and Laboratory
• Others

Amniotic Membrane Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the amniotic membrane market include Amnio Technology, LLC, Applied Biologics LLC, Amniox Medical, Inc., AlloCure, Alliqua BioMedical, Inc., FzioMed, Inc., Skye Biologics, Inc., IOP Ophthalmics, CESCA THERAPEUTICS, Bellicum Pharmaceuticals, and Human Regenerative Technologies, LLC. Expansion of product protocol is the key strategies adopted by the market players to expand their geographical presence. For instance, in September 2017, Amnio Technology, LLC, a leading manufacturer of advanced regenerative allografts derived from human amniotic tissues, announced the expansion of its product line with the launch of PalinGen InovoFlo.

Recent Development:

• In December 2023, Damon Dierker, OD, FAAO, shared latest updates in research on sutureless cryopreserved amniotic membrane for moderate-to-severe dry eye with short treatment duration. He discussed the groundbreaking potential of sutureless cryopreserved amniotic membrane therapy for moderate to severe dry eye. He discussed about showcasing the remarkable durability and efficacy of a single placement for up to three months. Notably, he reveals compelling data indicating that a shorter treatment duration of just 2 days can yield equivalent benefits, reshaping clinical recommendations and enhancing patient convenience.
•  In November 2022, A study in Plastic and Reconstructive Surgery, the Journal of the American Society of Plastic Surgeons, reported that AmnioBand® Membrane, an aseptically processed, dehydrated human amnion/chorion allograft (dHACA) developed by MTF Biologics, offers greater wound closure for those with chronic venous leg ulcers than standard of care alone. In fact, AmnioBand was shown to achieve full wound closure in 75 percent of these difficult to treat wounds after just 12 weeks of treatment. These results indicate that AmnioBand is one of the most cost-effective advanced treatment options for venous leg ulcers available today.

• Amnio Technology, LLC
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies

• Applied Biologics LLC
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Amniox Medical, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• AlloCure
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Alliqua BioMedical, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• FzioMed, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Skye Biologics, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• IOP Ophthalmics
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• CESCA THERAPEUTICS
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Bellicum Pharmaceuticals
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Human Regenerative Technologies, LLC
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Preview
   • Executive Summary
   • Key Findings—Global Outlook for medical carts Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Product
     • Market Snippet, By Application
     • Market Snippet, By End User
     • Market Snippet, By End-Users
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restrains
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Market Segmentation, By Product, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Lyophilization
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Cryopreserved
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Application, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Ophthalmology
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Surgical Wounds
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Others
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By End User, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Specialized Clinics
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Research Centers & Laboratory
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Global Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • U.S.
    • Canada
• Europe
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • UK
    • France
    • Germany
    • Russia
    • Italy
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific

• Latin America
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-Users , Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• GCC
• Israel
• South Africa
• Rest of Middle East

1. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
2. Company Profiles

• Amnio Technology, LLC
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Applied Biologics LLC
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Amniox Medical, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• AlloCure
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Alliqua BioMedical, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• FzioMed, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Skye Biologics, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• IOP Ophthalmics
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• CESCA THERAPEUTICS
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Bellicum Pharmaceuticals
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Human Regenerative Technologies, LLC
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies

The Last Word

• Future Impact
• About Us
• Contact